Literature DB >> 18668515

Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee.

Giovanni Cecchetto1, Elena Carretto, Gianni Bisogno, Patrizia Dall'Igna, Andrea Ferrari, Giovanni Scarzello, Alberto Donfrancesco, Rita Alaggio, Paolo Indolfi, Modesto Carli.   

Abstract

BACKGROUND: To evaluate the effect of radiotherapy (RT) in association with complete second look operation, histologically confirmed, on outcome of patients with IRS Gr.III non-alveolar RMS. PROCEDURE: We analyzed data from 39 patients (age: 0.5-194 months, median 52) who were enrolled between 1988 and 2005 in 2 consecutive Italian Studies, RMS 88 and RMS 96. All achieved a complete resection of the residual tumor after neoadjuvant chemotherapy; 27 did not receive any other local treatment: pelvic 8, extremities 6, head-neck-non-parameningeal 5, orbit 1, genito-urinary-bladder-prostate 3, trunk 2, abdomen 1, vagina 1; 12 were given RT (32-45 Gy), 5 before and 7 after the operation: genito-urinary-bladder-prostate 3, pelvic 3, abdominal 1, extremities 1, head-neck-parameningeal 1, head-neck-non-parameningeal 1, vagina 1, orbit 1. All received postoperative chemotherapy.
RESULTS: Median follow-up was 81 months (range 17-219 months). With RT: 10/12 patients are in first complete remission; 2/12 had a metastatic relapse (1 also local relapse), and both of them died of disease. Without RT: 16/27 maintained the first complete remission, however 1/16 died due to a second tumor; 8 suffered from local relapse (4 pelvic, 1 orbit, 1 vagina, 1 head-neck-non-parameningeal, 1 abdomen) and 3 of them died, 3 showed a metastatic recurrence (2 extremities, 1 pelvic) and 1 died.
CONCLUSIONS: Local relapses were more frequent for patients without RT, especially in pelvic sites. The two relapses after RT occurred in huge bladder-prostate RMS. Although the limited number of patients does not allow statistically significant conclusions, our experience suggests that RT may have a positive influence on local control for completely resected non-alveolar RMS. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18668515     DOI: 10.1002/pbc.21702

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  10 in total

1.  Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group.

Authors:  Beverly Raney; Julie Stoner; James Anderson; Richard Andrassy; Carola Arndt; Ken Brown; William Crist; Harold Maurer; Stephen Qualman; Moody Wharam; Eugene Wiener; William Meyer; Andrea Hayes-Jordan
Journal:  J Pediatr Surg       Date:  2010-11       Impact factor: 2.545

2.  Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:  Julie A Bradley; Mark L Kayton; Yueh-Yun Chi; Douglas S Hawkins; Jing Tian; John Breneman; Suzanne L Wolden; David Walterhouse; David A Rodeberg; Sarah S Donaldson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-08-20       Impact factor: 7.038

Review 3.  What is new in rhabdomyosarcoma management in children?

Authors:  Yasmin Gosiengfiao; Jennifer Reichek; David Walterhouse
Journal:  Paediatr Drugs       Date:  2012-12-01       Impact factor: 3.022

4.  Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.

Authors:  John Breneman; Jane Meza; Sarah S Donaldson; R Beverly Raney; Suzanne Wolden; Jeff Michalski; Fran Laurie; David A Rodeberg; William Meyer; David Walterhouse; Douglas S Hawkins
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

5.  Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Authors:  David A Rodeberg; Moody D Wharam; Elizabeth R Lyden; Julie A Stoner; Kenneth Brown; Suzanne L Wolden; Charles N Paidas; Sarah S Donaldson; Douglas S Hawkins; Sheri L Spunt; Carola A Arndt
Journal:  Int J Cancer       Date:  2014-12-10       Impact factor: 7.396

Review 6.  Pediatric genitourinary tumors.

Authors:  Sharon M Castellino; Anibal R Martinez-Borges; Thomas W McLean
Journal:  Curr Opin Oncol       Date:  2009-05       Impact factor: 3.645

7.  Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:  Timothy B Lautz; Yueh-Yun Chi; Minjie Li; Suzanne L Wolden; Dana L Casey; Jonathan C Routh; Candace F Granberg; Odion Binite; Erin R Rudzinski; Douglas S Hawkins; Rajkumar Venkatramani; David A Rodeberg
Journal:  Cancer       Date:  2020-10-20       Impact factor: 6.921

Review 8.  Pediatric genitourinary oncology.

Authors:  Francisco Tibor Dénes; Ricardo Jordão Duarte; Lílian Maria Cristófani; Roberto Iglesias Lopes
Journal:  Front Pediatr       Date:  2013-12-16       Impact factor: 3.418

Review 9.  Rhabdomyosarcoma in adolescent and young adult patients: current perspectives.

Authors:  Daniela Egas-Bejar; Winston W Huh
Journal:  Adolesc Health Med Ther       Date:  2014-06-17

Review 10.  Recent advances in pediatric bladder malignancies.

Authors:  Roberto Iglesias Lopes; Marcos Figueiredo Mello; Armando J Lorenzo
Journal:  F1000Res       Date:  2020-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.